Pediatric Vaccine - United States Industry Size, Share, Trends, Analysis and Forecast 2017 – 2024

New York, NY -- (SBWire) -- 11/07/2017 --United States Pediatric Vaccine Industry

Latest Report on Pediatric Vaccine Market United States Analysis & 2024 Forecast Research Study

United States Pediatric Vaccine market is likely to reach nearly US$ 10 Billion by 2024.

Growth in US pediatric vaccine market can be attributed to factors such as increased disease awareness, growing public acceptance, increasing government focus on immunization programs and increased government funding for the vaccine development.

The research report titled "United States Pediatric Vaccine Market 2017 – Demand, Insights, Analysis, Opportunities Segmentation and Forecast to 2024" examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the United States pediatric vaccine market.

Try Sample Report @  https://www.wiseguyreports.com/sample-request/2388879-united-states-pediatric-vaccine-market-2017-demand-insights-analysis-opportunities-segmentation

The report contains a granular analysis of the market segmentation, reveal facts on the market size, volume and revenues and provides forecasts through 2024. The report also provides a deep and thorough evaluation of the top 10 pediatric vaccines by disease indication. On the basis of disease indication, the top 10 pediatric vaccines provide an in-depth analysis of doses administered, number of children being vaccinated and market size. The report also explores detailed description of growth drivers and inhibitors of the United States pediatric vaccine market.

The report concludes with the profiles of major players in the United States pediatric vaccine market. The key market players are evaluated on various parameters such as company overview, pediatric vaccine portfolios and latest development & trends of the pediatric vaccine market.

Major Pediatric Vaccines (Disease Indication) Covered Under This Report Are:

Diphtheria, Tetanus & Pertussis (DTap)
Hepatitis A
Varicella/Chicken Pox
Pneumococcal
Haemophilus Influenzae Type B (HIB)
Polio
Rotavirus
Hepatitis B
Influenza Pediatric
Measles, Mumps & Rubella (MMR)

Key Companies Covered in the Report are as follows:

Sanofi Pasteur
GlaxoSmithKline(GSK)
Merck & Co.
Pfizer Inc
Grifols

Key Deliverables in the Study

Market Definition for the specified topic along with identification of key drivers and inhibitors for the market

It provides a growth map over time to understand the industry growth rate

It provides a seven-year forecast assessed based on how the market is predicted to grow

It helps in understanding the key product segments and their future

It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

A comprehensive list of key market players along with the analysis of their current pediatric vaccines portfolios and latest development and trends.

For Detailed Reading Please visit WiseGuy Reports @   https://www.wiseguyreports.com/reports/2388879-united-states-pediatric-vaccine-market-2017-demand-insights-analysis-opportunities-segmentation

Some points from table of content:

Executive Summary
Market Size & Analysis: United States Pediatric Vaccine (2010 – 2024)

3. United States Pediatric Vaccine Market Share and Y–o–Y Growth (%)

4. Key Market Drivers and Inhibitors of the United States Pediatric Vaccine Market
4.1 Market Drivers
4.2 Market Inhibitors

5. United States Pediatric Vaccine Market – By Disease Indication (2010 – 2024)
5.1 Diphtheria, Tetanus & Pertussis (DTap)
5.1.1 Doses Administered (Volume)
5.1.2 Number of Children Being Vaccinated (Volume)
5.1.3 Market Size and Forecast (Value)
5.2 Hepatitis A
5.2.1 Doses Administered (Volume)
5.2.2 Number of Children Being Vaccinated (Volume)
5.2.3 Market Size and Forecast (Value)
5.3 Varicella / Chicken Pox
5.3.1 Doses Administered (Volume)
5.3.2 Number of Children Being Vaccinated (Volume)
5.3.3 Market Size and Forecast (Value)
5.4 Pneumococcal
5.4.1 Doses Administered (Volume)
5.4.2 Number of Children Being Vaccinated (Volume)
5.4.3 Market Size and Forecast (Value)
5.5 Haemophilus Influenzae Type B (HIB)
5.5.1 Doses Administered (Volume)
5.5.2 Number of Children Being Vaccinated (Volume)
5.5.3 Market Size and Forecast (Value)
5.6 Polio
5.6.1 Doses Administered (Volume)
5.6.2 Number of Children Being Vaccinated (Volume)
5.6.3 Market Size and Forecast (Value)
5.7 Rotavirus
5.7.1 Doses Administered (Volume)
5.7.2 Number of Children Being Vaccinated (Volume)
5.7.3 Market Size and Forecast (Value)
5.8 Hepatitis B
5.8.1 Doses Administered (Volume)
5.8.2 Number of Children Being Vaccinated (Volume)
5.8.3 Market Size and Forecast (Value)
5.9 Influenza Pediatric
5.9.1 Doses Administered (Volume)
5.9.2 Number of Children Being Vaccinated (Volume)
5.9.3 Market Size and Forecast (Value)
5.10 Measles, Mumps & Rubella (MMR)
5.10.1 Doses Administered (Volume)
5.10.2 Number of Children Being Vaccinated (Volume)
5.10.3 Market Size and Forecast (Value)

Continued…….

For more information or any query mail at sales@wiseguyreports.com

About Wise Guy Reports
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym